Antitumor efficacy of lymphokine-activated killer cells and recombinant interleukin-2 in vivo: survival benefit and mechanisms of tumor escape in mice undergoing immunotherapy. (Q54433454)
Jump to navigation
Jump to search
scientific article published in February 1986
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Antitumor efficacy of lymphokine-activated killer cells and recombinant interleukin-2 in vivo: survival benefit and mechanisms of tumor escape in mice undergoing immunotherapy. |
scientific article published in February 1986 |
Statements
Antitumor efficacy of lymphokine-activated killer cells and recombinant interleukin-2 in vivo: survival benefit and mechanisms of tumor escape in mice undergoing immunotherapy. (English)
Rosenberg SA
Mulé JJ
Ettinghausen SE
Spiess PJ
Shu S
1 February 1986
46
2
676-683